Compare CCEL & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCEL | GSIW |
|---|---|---|
| Founded | 1989 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Managed Health Care | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.8M | 33.9M |
| IPO Year | 1997 | 2023 |
| Metric | CCEL | GSIW |
|---|---|---|
| Price | $4.12 | $0.15 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.8K | ★ 462.3K |
| Earning Date | 10-15-2025 | 01-01-0001 |
| Dividend Yield | ★ 10.03% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $31,747,500.00 | $5,368,221.00 |
| Revenue This Year | $0.30 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 283.23 |
| 52 Week Low | $3.57 | $0.09 |
| 52 Week High | $8.86 | $1.79 |
| Indicator | CCEL | GSIW |
|---|---|---|
| Relative Strength Index (RSI) | 49.45 | 45.30 |
| Support Level | $4.04 | $0.14 |
| Resistance Level | $4.08 | $0.15 |
| Average True Range (ATR) | 0.18 | 0.01 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 62.79 | 47.41 |
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.